Urology · Charlotte, NC
NPI
1619231321
Since 2012
Specialty
Urology
Code 208800000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
325 Hawthorne Ln Ste 300
Charlotte, NC, 28204
Phone (704) 372-5180
Groups this clinician bills Medicare through
Medicare paid, 2024
$391K
3,934 services
Medicare patients, 2024
617
Average age 76
Drug cost, 2024
$24.2M
4,022 prescriptions
Company payments, 2025
$1,697
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William B Townsend was code J9217 (leuprolide acetate (for depot suspension), 7.5 mg), 682 times for 131 patients. In total William B Townsend billed 3,934 services in 93 codes, and Medicare paid $391K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 682 | 131 | $137.22 | $94K |
| 99214 Office E&M - Established | Office | 405 | 317 | $88.18 | $36K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 230 | 194 | $12.49 | $2,873 |
| 96402 Chemotherapy Administration | Office | 227 | 132 | $26.20 | $5,948 |
| 81002 Clinical Chemistry | Office | 210 | 179 | $3.38 | $709 |
| 99213 Office E&M - Established | Office | 152 | 143 | $56.28 | $8,555 |
| 52000 Cystourethroscopy | Office | 123 | 96 | $171.88 | $21K |
| 99215 Office E&M - Established | Office | 109 | 94 | $129.96 | $14K |
| 51798 Ultrasound - Nonspecific | Office | 101 | 88 | $7.31 | $738 |
| 81003 Clinical Chemistry | Office | 66 | 60 | $2.20 | $145 |
| 99204 Office E&M - New | Office | 56 | 56 | $116.08 | $6,500 |
| J1580 Injection, garamycin, gentamicin, up to 80 mg | Office | 33 | 19 | $1.96 | $64.6 |
| 74420 Standard X-ray | Facility | 32 | 31 | $19.02 | $609 |
| 99203 Office E&M - New | Office | 29 | 29 | $79.44 | $2,304 |
| 52332 Cystourethroscopy | Facility | 25 | 21 | $96.72 | $2,418 |
By year: 2022 $489K for 2,207 services; 2023 $346K for 14,256 services; 2024 $391K for 3,934 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 210 | 179 | $3.38 | $709 |
| 81003 Clinical Chemistry | 66 | 60 | $2.20 | $145 |
| 81000 Clinical Chemistry | 17 | 17 | $3.94 | $66.98 |
Medicare prescription drug claims, 2024
In 2024, the drug William B Townsend prescribed most often to Medicare patients was Erleada (Apalutamide), with 662 prescriptions and refills. In total William B Townsend wrote 4,022 Medicare prescriptions that cost $24.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Erleada Apalutamide | 662 | 688 | 89 | $9.6M |
| Nubeqa Darolutamide | 492 | 503 | 69 | $6.4M |
| Orgovyx Relugolix | 466 | 466 | 72 | $1.2M |
| Xtandi Enzalutamide | 376 | 377 | 49 | $5.2M |
| Tamsulosin Hcl Generic | 369 | 968 | 150 | $5,066 |
| Prednisone Generic | 288 | 403 | 55 | $1,156 |
| Abiraterone Acetate Generic | 257 | 261 | 37 | $292K |
| Yonsa Abiraterone Acet,submicronized | 129 | 135 | 19 | $1.3M |
| Finasteride Generic | 126 | 361 | 50 | $1,303 |
| Ciprofloxacin Hcl Generic | 124 | 124 | 118 | $370 |
| Gemtesa Vibegron | 98 | 179 | 28 | $86K |
| Cephalexin Generic | 56 | 84 | 46 | $508 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 48 | 86 | 36 | $241 |
| Tramadol Hcl Generic | 48 | 48 | 45 | $81.96 |
| Diazepam Generic | 44 | 44 | 41 | $45.65 |
Brand drugs: 2,264 claims; generic drugs: - claims; opioid claims: 93.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William B Townsend $1,697 ($1,697 in general payments such as food, travel and fees) from 15 companies. The largest payer was Axogen with $273.
| Company | Payments | Amount |
|---|---|---|
| Axogen AXGN | 4 | $273 |
| Dendreon Pharmaceuticals LLC | 10 | $241 |
| Boston Scientific Corporation BSX | 4 | $163 |
| Astellas Pharma US Inc 4503.T | 9 | $162 |
| Immunitybio, Inc. IBRX | 1 | $157 |
| Calyxo, Inc. | 1 | $126 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $122 |
| Janssen Biotech, Inc. JNJ | 1 | $99.99 |
| Seagen Inc. PFE | 1 | $99.99 |
| Blue Earth Diagnostics | 3 | $62.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.